top of page
Search
  • Writer's pictureJeffrey White

Akumin - Strong Q2/20 Results

Akumin (AKU.U, AKU) released very strong Q2 results after the close on August 12th.



Some highlights:

  • Despite an approx. 30% despite decline in imaging volumes in Q2 as a result of COVID-19, AKU generated over US$13.7mm in Adjusted EBITDA in the quarter excluding any benefit from the CARES ACT or other programs– a very strong result!

  • Akumin’s EBITDA margins rebounded to pre-pandemic levels of 26%(!), a testament to the cost-containment and integration initiatives that the company implemented in the quarter.

  • Akumin finished the quarter with $28.1 million cash-on-hand, an increase of $11.5 million in the cash position! Akumin did not draw down on its revolver and net debt actually decreased – strong evidence of the resiliency of the Akumin platform as an essential healthcare service.

The Q2 2020 Investor Presentation is available for download on Akumin’s website at https://akumin.com/wp-content/uploads/2020-Q2-Investor-Presentation.pdf. A replay of the conference call will also be available until Thursday, August 20, 2020 by calling 416-849-0833 or toll-free 1-855-859-2056, using passcode number 7967905.


Please give me a call or send me an email if you would like more details.


Jeffrey White

(416) 274-7762

rjwhite@hingemarkets.com

6 views0 comments

Recent Posts

See All

Akumin Releases Q3 Results and 2022 Guidance

It has been a busy week at Akumin! There have been a number of important developments including: The release of our Q3 consolidated financial results on Dec 13th/21, which includes 1 month of combined

Comentários


bottom of page